Stockreport

Gain Therapeutics to Present at the 38th Annual ROTH Conference

Gain Therapeutics, Inc.  (GANX) 
PDF BETHESDA, Md., March 19, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the [Read more]